|
|
|
Insider
Information: |
Boyd Steven |
Relationship: |
10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
18 |
|
Direct
Shares |
47,075,098 |
|
Indirect Shares
|
40,287,245 |
|
|
Direct
Value |
$128,455,406 |
|
|
Indirect Value
|
$40,265,984 |
|
|
Total
Shares |
87,362,343 |
|
|
Total
Value |
$168,721,391 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
99
|
96
|
Stock
price went up :
|
54
|
46
|
Stock
price went down : |
45
|
50
|
|
|
|
Gain/Loss Ratio : |
1.2
|
1.2
|
Percentage
Gain/Loss : |
-16.7%
|
8,928.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2023-06-27 |
34,370 |
2023-06-27 |
731,458 |
Premium* |
|
Dynatronics Corp |
DYNT |
10% Owner |
2017-03-21 |
500,000 |
2017-03-21 |
1,000,000 |
Premium* |
|
Kiora Pharmaceuticals |
KPRX |
10% Owner |
2021-01-06 |
3,346,601 |
2021-08-02 |
785,000 |
Premium* |
|
Fresh Tracks Therapeutics Ord Shs |
FRTX |
10% Owner |
2019-01-10 |
2,170,000 |
2019-01-10 |
2,170,000 |
Premium* |
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2018-02-06 |
6,936,000 |
2018-02-06 |
6,936,000 |
Premium* |
|
Cassava Sciences Inc |
SAVA |
10% Owner |
2018-10-03 |
1,651,340 |
2018-10-03 |
0 |
Premium* |
|
Del Friscos Restaurant Group, Llc |
DFRG |
10% Owner |
2019-09-25 |
0 |
2019-09-25 |
0 |
Premium* |
|
Valeritas Holdings Inc |
VLRX |
10% Owner |
2019-12-20 |
0 |
2019-12-20 |
0 |
Premium* |
|
Bio-Path Holdings, Inc. |
BPTH |
10% Owner |
2019-01-18 |
129,298 |
2019-01-18 |
129,298 |
Premium* |
|
AYTU BIOSCIENCE, INC |
AYTU |
Director |
2021-03-29 |
1,342,378 |
2021-03-29 |
1,342,378 |
Premium* |
|
Achieve Life Sciences Inc |
ACHV |
10% Owner |
2019-06-11 |
843,776 |
2019-06-11 |
843,776 |
Premium* |
|
AMAG Pharmaceuticals Inc |
AMAG |
10% Owner |
2020-03-16 |
4,120,000 |
2020-03-16 |
348,000 |
Premium* |
|
Onconova Therapeutics, Inc. |
ONTX |
10% Owner |
2019-09-23 |
816,702 |
2019-09-23 |
816,702 |
Premium* |
|
Vaxart Inc |
VXRT |
Director |
2020-06-29 |
145,523 |
2020-06-29 |
145,523 |
Premium* |
|
Tetraphase Pharmaceuticals Inc |
TTPH |
Director, 10% Owner |
2020-07-28 |
0 |
2020-07-28 |
0 |
Premium* |
|
Tenax Therapeutics Inc |
TENX |
Director, 10% Owner |
2020-09-08 |
2,019,995 |
2020-09-08 |
2,019,995 |
Premium* |
|
Cyclo Therapeutics, Inc |
CYTH |
10% Owner |
2020-09-30 |
15,795,769 |
2020-09-30 |
15,795,769 |
Premium* |
|
ReShape Lifesciences Inc |
RSLS |
10% Owner |
2021-06-28 |
7,223,346 |
2021-06-28 |
7,223,346 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
790 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 25 of 32
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VXRT |
Vaxart Inc |
Director |
|
2020-06-03 |
4 |
S |
$2.77 |
$1,108,000 |
D/D |
(400,000) |
7,000,000 |
0 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2021-08-05 |
4 |
B |
$2.77 |
$69,295 |
I/I |
25,000 |
39,225,000 |
1.5 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2021-08-18 |
4 |
B |
$2.78 |
$55,550 |
I/I |
20,000 |
39,300,000 |
2.25 |
% |
|
VXRT |
Vaxart Inc |
Director |
|
2020-05-11 |
4 |
S |
$2.79 |
$3,627,000 |
D/D |
(1,300,000) |
14,400,000 |
0 |
% |
|
VXRT |
Vaxart Inc |
Director |
|
2020-05-15 |
4 |
S |
$2.82 |
$1,293,362 |
D/D |
(458,639) |
11,000,000 |
0 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
10% Owner |
|
2021-08-06 |
4 |
B |
$2.83 |
$70,630 |
I/I |
25,000 |
39,250,000 |
1.5 |
% |
|
ACHV |
Achieve Life Sciences Inc |
10% Owner |
|
2019-06-11 |
4 |
S |
$2.85 |
$134,821 |
D/D |
(47,182) |
796,594 |
0 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2020-05-18 |
4 |
S |
$2.86 |
$1,859,000 |
D/D |
(650,000) |
10,350,000 |
0 |
% |
|
VXRT |
Vaxart Inc |
Director |
|
2020-05-22 |
4 |
S |
$2.86 |
$572,000 |
D/D |
(200,000) |
8,600,000 |
0 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2019-09-06 |
4 |
B |
$2.95 |
$2,950,000 |
D/D |
1,000,000 |
20,683,233 |
3.92 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2020-04-30 |
4 |
S |
$2.96 |
$13,125,516 |
D/D |
(4,434,296) |
18,600,000 |
0 |
% |
|
VXRT |
Vaxart Inc |
Director |
|
2020-05-13 |
4 |
S |
$2.97 |
$1,561,080 |
D/D |
(525,616) |
12,293,308 |
0 |
% |
|
VXRT |
Vaxart Inc |
Director |
|
2020-05-21 |
4 |
S |
$2.97 |
$1,188,000 |
D/D |
(400,000) |
8,800,000 |
0 |
% |
|
KPRX |
Kiora Pharmaceuticals |
Director |
|
2021-07-29 |
4 |
S |
$3.00 |
$1,200,000 |
I/I |
(400,000) |
1,045,963 |
0 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2020-04-29 |
4 |
S |
$3.01 |
$2,629,638 |
D/D |
(873,634) |
23,034,296 |
0 |
% |
|
VXRT |
Vaxart Inc |
Director |
|
2020-05-12 |
4 |
S |
$3.02 |
$4,774,850 |
D/D |
(1,581,076) |
12,818,924 |
0 |
% |
|
VXRT |
Vaxart Inc |
Director |
|
2020-05-14 |
4 |
S |
$3.02 |
$2,520,700 |
D/D |
(834,669) |
11,458,639 |
0 |
% |
|
KPRX |
Kiora Pharmaceuticals |
Director |
|
2019-09-30 |
4 |
B |
$3.11 |
$15,613 |
D/D |
5,001 |
1,792,500 |
3.92 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2018-12-28 |
4 |
B |
$3.12 |
$82,677 |
D/D |
26,499 |
18,116,499 |
3.92 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2019-09-04 |
4 |
B |
$3.13 |
$3,756,000 |
D/D |
1,200,000 |
19,683,233 |
3.92 |
- |
|
KPRX |
Kiora Pharmaceuticals |
Director |
|
2019-09-29 |
4 |
B |
$3.13 |
$1,875,000 |
D/D |
600,000 |
1,787,499 |
3.92 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2018-12-31 |
4 |
B |
$3.18 |
$39,081 |
D/D |
12,300 |
18,128,799 |
3.92 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2020-05-20 |
4 |
S |
$3.19 |
$3,668,500 |
D/D |
(1,150,000) |
9,200,000 |
0 |
% |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2019-08-12 |
4 |
B |
$3.20 |
$44,704 |
I/I |
13,970 |
313,970 |
2.25 |
- |
|
AVTX |
Avalo Therapeutics, Inc |
Director |
|
2019-08-29 |
4 |
B |
$3.21 |
$55,125 |
D/D |
17,173 |
18,458,642 |
3.92 |
- |
|
790 Records found
|
|
Page 25 of 32 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|